Online Trial Tracker - Larvol Sigma

SYHX2001 / CSPC Pharma

Welcome, Profile Billing Logout

1 Trials

Active Trials Industry lead sponsorIndustry collaborator

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

SYHX2001 / CSPC Pharma

NCT05407909: To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors

Recruiting

176

RoW

SYHX2001

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Advanced or Metastatic Solid Tumors

01/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites